M
Maddalena Peghin
Researcher at University of Udine
Publications - 81
Citations - 1818
Maddalena Peghin is an academic researcher from University of Udine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 57 publications receiving 887 citations. Previous affiliations of Maddalena Peghin include Autonomous University of Barcelona & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Important new therapies for methicillin-resistant Staphylococcus aureus.
TL;DR: The efficacy and safety of recently approved anti-MRSA molecules as well as some newer agents currently under investigation are reviewed with a specific focus on the potential role of these drugs in everyday clinical practice.
Journal ArticleDOI
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.
Mario Tumbarello,Francesca Raffaelli,Maddalena Peghin,Angela Raffaella Losito,Luigi Chirico,Gabriele Giuliano,Teresa Spanu,Assunta Sartor,Barbara Fiori,Matteo Bassetti +9 more
TL;DR: Risk-factor assessment can identify UTIs in hospitalised patients likely to be caused by MDR P. aeruginosa strains, thereby facilitating targeted infection-control and timelier, effective treatment of these infections.
Journal ArticleDOI
Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors
Marco Colizzi,Maddalena Peghin,Mariano De Martino,Giulia Bontempo,Valentina Gerussi,Alvisa Palese,Miriam Isola,Carlo Tascini,Matteo Balestrieri +8 more
TL;DR: In this article , a prospective study investigated mental health symptoms associated with COVID-19 and its determinants over a 12-month period following the disease onset in all consecutive adult inpatients and outpatients attending a tertiary referral hospital from March to May 2020.
Journal ArticleDOI
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam.
TL;DR: The current and future role CAZ-AVI in the pediatric population with suspected or confirmed MDR-GN infections is described and cephalosporin/β-lactamase inhibitor combination with broad antibacterial spectrum is described.
Journal ArticleDOI
Estimated burden of fungal infections in Italy.
Matteo Bassetti,Alessia Carnelutti,Maddalena Peghin,Franco Aversa,Francesco Barchiesi,Corrado Girmenia,Livio Pagano,Maurizio Sanguinetti,Anna Maria Tortorano,Maria Teresa Montagna,Pierluigi Viale,Claudio Viscoli,David W. Denning +12 more